kynurenic acid has been researched along with Malignant Melanoma in 4 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Rad Pour, S | 1 |
Morikawa, H | 1 |
Kiani, NA | 1 |
Yang, M | 1 |
Azimi, A | 1 |
Shafi, G | 1 |
Shang, M | 1 |
Baumgartner, R | 1 |
Ketelhuth, DFJ | 1 |
Kamleh, MA | 1 |
Wheelock, CE | 1 |
Lundqvist, A | 1 |
Hansson, J | 1 |
Tegnér, J | 1 |
Walczak, K | 3 |
Langner, E | 1 |
Makuch-Kocka, A | 1 |
Szelest, M | 2 |
Szalast, K | 2 |
Marciniak, S | 1 |
Plech, T | 3 |
Kazimierczak, P | 1 |
1 review available for kynurenic acid and Malignant Melanoma
Article | Year |
---|---|
A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes.
Topics: Animals; Carbazoles; Chloracne; Dermatitis, Atopic; Humans; Hyperpigmentation; Kynurenic Acid; Kynur | 2021 |
3 other studies available for kynurenic acid and Malignant Melanoma
Article | Year |
---|---|
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Topics: B7-H1 Antigen; CD4-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Coculture Techniques; Cult | 2019 |
Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells-In Vitro Studies.
Topics: Basic Helix-Loop-Helix Transcription Factors; Carbazoles; Cell Cycle; Cell Line, Tumor; Cell Prolife | 2020 |
UVB Radiation and Selected Tryptophan-Derived AhR Ligands-Potential Biological Interactions in Melanoma Cells.
Topics: Basic Helix-Loop-Helix Transcription Factors; Excitatory Amino Acid Antagonists; Humans; Kynurenic A | 2021 |